Stay updated on Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:16:49.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a minor metadata update with no changes to study information.
    Difference
    0.1%
    Check dated 2026-03-11T14:07:53.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Adds explicit institution names (Moffitt Cancer Center and Research Institute) and a 'Helpful Links Provided by' section to the study page, clarifying sponsorship and related resources.
    Difference
    0.2%
    Check dated 2026-03-04T08:59:21.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Deleted footer elements include the Moffitt sponsor attribution and the Helpful Links section. This reduces visibility of institutional affiliation and access to related resources on the study page.
    Difference
    0.2%
    Check dated 2026-02-18T04:08:53.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the previous funding-status notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:09:56.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    A government funding notice has been added to the page, and the revision version updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-03T23:48:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page.